X-70445249-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_021120.4(DLG3):āc.48G>Cā(p.Val16Val) variant causes a synonymous change. The variant allele was found at a frequency of 0.00000286 in 1,050,140 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: not found (cov: 24)
Exomes š: 0.0000029 ( 0 hom. 0 hem. )
Consequence
DLG3
NM_021120.4 synonymous
NM_021120.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.77
Genes affected
DLG3 (HGNC:2902): (discs large MAGUK scaffold protein 3) This gene encodes a member of the membrane-associated guanylate kinase protein family. The encoded protein may play a role in clustering of NMDA receptors at excitatory synapses. It may also negatively regulate cell proliferation through interaction with the C-terminal region of the adenomatosis polyposis coli tumor suppressor protein. Mutations in this gene have been associated with X-linked cognitive disability. Alternatively spliced transcript variants have been described. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant X-70445249-G-C is Benign according to our data. Variant chrX-70445249-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 1743971.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLG3 | NM_021120.4 | c.48G>C | p.Val16Val | synonymous_variant | 1/19 | ENST00000374360.8 | NP_066943.2 | |
DLG3 | XM_006724625.3 | c.48G>C | p.Val16Val | synonymous_variant | 1/20 | XP_006724688.1 | ||
DLG3 | XM_011530883.2 | c.48G>C | p.Val16Val | synonymous_variant | 1/19 | XP_011529185.1 | ||
DLG3 | XM_006724626.3 | c.48G>C | p.Val16Val | synonymous_variant | 1/20 | XP_006724689.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLG3 | ENST00000374360.8 | c.48G>C | p.Val16Val | synonymous_variant | 1/19 | 1 | NM_021120.4 | ENSP00000363480.3 | ||
DLG3 | ENST00000194900.8 | c.48G>C | p.Val16Val | synonymous_variant | 1/21 | 5 | ENSP00000194900.4 | |||
DLG3 | ENST00000463252.5 | n.114G>C | non_coding_transcript_exon_variant | 1/19 | 5 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 genomes
Cov.:
24
GnomAD3 exomes AF: 0.0000198 AC: 2AN: 100762Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 36216
GnomAD3 exomes
AF:
AC:
2
AN:
100762
Hom.:
AF XY:
AC XY:
0
AN XY:
36216
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000286 AC: 3AN: 1050140Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 343010
GnomAD4 exome
AF:
AC:
3
AN:
1050140
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
343010
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 24
GnomAD4 genome
Cov.:
24
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 20, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at